News & Publications
The latest news and publications about Merkel cell carcinoma and merkelcell.org.
We are very excited to announce that this year we held our first ever online Merkel CELLebration in lieu of our annual Merkel Dinner. The event took place on Zoom on Monday, September 14, 2020 from 3-5 PM PDT. The event included a presentation of new research and clinical developments in MCC, as ...
Read more →Nghiem Lab research team demonstrates effectiveness of Single fraction adjuvant radiation therapy for treating patients with Merkel cell carcinoma (MCC). The team, consisting of investigators from UW Divisions of Dermatology and Medical Oncology and the Departments of Radiation Oncology Radiology, ...
Read more →Dr. Paul Nghiem, professor and head of Dermatology at the University of Washington and expert in Merkel cell carcinoma (MCC), joins the Seattle Translational Tumor Research leadership team as the Deputy Director for Skin/Cutaneous Oncology. As a hub for collaboration and innovation, Seattle Trans...
Read more →Click below for a statement from the National Comprehensive Cancer Network regarding coordination of care during the COVID-19 pandemic. Click below for a statement from the National Comprehensive Cancer Network regarding COVID-19 vaccination for cancer patients.
Read more →Amidst delays to treatment plans brought about by COVID-19, the FDA has approved a new dosing regimen of 400 mg every six weeks for pembrolizumab. The approval was based on pharmacokinetic modeling and exposure-response analyses that compared the predicted exposure of pembrolizumab 400 mg every s...
Read more →Dear Colleagues, Following cancellation of the AAD meeting in Denver, we initially planned to proceed with a virtual (Zoom-based) meeting for our Merkel interest group. We had 5 very interesting talks lined up & all speakers were available. Given the urgency of COVID-19-associated event...
Read more →Dear friends of Merkel cell carcinoma research, During this time of giving and celebrations, I want to let you know how appreciative our Merkel Team is of your support. This year was one of many exciting milestones that I am thrilled to share with you. We have written an annual update lette...
Read more →A study with the longest follow-up of immunotherapy as the first line treatment for patients with advanced MCC has showed improved overall survival and response rate compared to controls. The study included 50 treatment naïve adults with advanced MCC who received a median of 10.5 doses of pembroliz...
Read more →3 generations of mentor-mentees gathered in Aomori Japan at the Japanese Society for Investigative Dermatology. DOM members Drs Masaoki Kawasumi, Tomoko Akaike, and Paul Nghiem, all gave plenary session talks. Left to right: Tomoko Akaike is a Japanese dermatologist doing a clinical research ...
Read more →